Who Paid My Doc
Claire Pomeroy
Infectious Disease Sacramento, CA Medical Doctor
NPI 1174595078 CMS profile 396552
4150 V St, Suite 1100, Sacramento, CA 95817
General payments
$2,625,953
Research payments
$0
Ownership & investment interest
$3,899,543
Through program year 2025, Claire Pomeroy of Sacramento, CA is reported in the CMS Open Payments database as having received $2,625,953 across 371 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $3,899,543 across 21 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Infectious Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
13 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $403,612 | 51 | |
| 2024 | General | $358,977 | 75 | |
| 2023 | General | $346,356 | 42 | |
| 2022 | General | $361,897 | 39 | |
| 2021 | General | $373,737 | 24 | |
| 2020 | General | $359,156 | 27 | |
| 2019 | General | $422,218 | 113 | |
| 2025 | Ownership | $1,137,970 | 1 | |
| 2024 | Ownership | $934,774 | 6 | |
| 2023 | Ownership | $833,380 | 5 | |
| 2022 | Ownership | $551,808 | 4 | |
| 2021 | Ownership | $210,372 | 3 | |
| 2020 | Ownership | $231,238 | 2 |
Beside peers
- Claire Pomeroy
- Infectious Disease median
- Middle half of Infectious Disease
- National median
In program year 2025, general payments to Claire Pomeroy were reported at $403,612. Among 3,905 Infectious Disease profiles paid that year, the median was $188 and the middle half received between $57 and $766.
Show as a table
| Year | Claire Pomeroy | Infectious Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $422,218 | $190 | $60–$862 | $163 |
| 2020 | $359,156 | $124 | $32–$606 | $114 |
| 2021 | $373,737 | $148 | $38–$905 | $132 |
| 2022 | $361,897 | $166 | $50–$834 | $149 |
| 2023 | $346,356 | $171 | $57–$787 | $160 |
| 2024 | $358,977 | $176 | $52–$752 | $164 |
| 2025 | $403,612 | $188 | $57–$766 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
371 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Infectious Disease in California
Related records
Infectious Disease in California
Practitioners in the same specialty and state, ranked by reported value.
All Infectious Disease
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.